AI
-
Business & Markets Pathos AI Secures $237M in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline
Insider Brief PRESS RELEASE — Pathos AI, Inc., a clinical-stage AI and technology company advancing its own therapeutic pipeline of drugs, announced the closing of a $237 million Series E financing round at a post-money valuation… -
Business & Markets France Sets 2027 Autonomous Vehicle Approval Path as Stellantis, Wayve, Bolt and G7 Pitch Pilots
-
Technology & Infrastructure · Applications & agents Microsoft’s AI Diagnostic System Outperforms Generalist Doctors on Complex Cases, Science Study Finds
-
Business & Markets Nebius Secures $3.5B Citi Facility to Expand AI Cloud Capacity
-
Business & Markets · Enterprise Spotify Bets on AI Agents as a Growth Driver After Strong Third Quarter
-
Technology & Infrastructure · Applications & agents Blackstone Positions Itself at the Center of AI Financing as Neocloud Debt Concerns Grow
-
Business & Markets Nirva Announces $25M in Funding for AI Pendant That Listens Only to Its Wearer
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.